Literature DB >> 23413147

Indoleamine 2,3-dioxygenase activity as a potential biomarker of immune suppression during visceral leishmaniasis.

Jean-Pierre Gangneux1, Yves Poinsignon, Ludovic Donaghy, Laurence Amiot, Karin Tarte, Charles Mary, Florence Robert-Gangneux.   

Abstract

Leishmania parasites induce an immunomodulation by subverting the host immune response towards a CD4(+) Th2 lymphocytic cell response that favors parasite persistence. Here, we report that after successful treatment of visceral leishmaniasis due to Leishmania infantum, an immune reconstitution syndrome revealing hip septic arthritis was associated with a switch from Th2 towards a Th1 cytokine profile, and a decrease in the level of immunomodulating factors, such as soluble HLA-G and indoleamine 2,3-dioxygenase (IDO) activity. We then measured IDO activity in a cohort of 39 patients and uninfected control subjects. Results showed significantly enhanced IDO activity in patients with visceral Leishmania infection, compared with uninfected control subjects (P < 0.001), but also compared with treated patients (P < 0.05). A decrease in IDO activity could constitute a relevant biomarker for the restoration of the immune response during visceral leishmaniasis.

Entities:  

Keywords:  3-dioxygenase; HLA-G; Indoleamine 2; Leishmania; immune reconstitution syndrome; immune response; visceral leishmaniasis

Mesh:

Substances:

Year:  2013        PMID: 23413147     DOI: 10.1177/1753425912473170

Source DB:  PubMed          Journal:  Innate Immun        ISSN: 1753-4259            Impact factor:   2.680


  8 in total

Review 1.  Systematic review of biomarkers to monitor therapeutic response in leishmaniasis.

Authors:  Anke E Kip; Manica Balasegaram; Jos H Beijnen; Jan H M Schellens; Peter J de Vries; Thomas P C Dorlo
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

2.  Transcriptional profiling of the spleen in progressive visceral leishmaniasis reveals mixed expression of type 1 and type 2 cytokine-responsive genes.

Authors:  Claudia M Espitia; Omar A Saldarriaga; Bruno L Travi; E Yaneth Osorio; Alvaro Hernandez; Mark Band; Mandakini J Patel; Audrie A Medina; Michael Cappello; Andrew Pekosz; Peter C Melby
Journal:  BMC Immunol       Date:  2014-11-26       Impact factor: 3.615

3.  Transcriptional Profiling in Experimental Visceral Leishmaniasis Reveals a Broad Splenic Inflammatory Environment that Conditions Macrophages toward a Disease-Promoting Phenotype.

Authors:  Fanping Kong; Omar A Saldarriaga; Heidi Spratt; E Yaneth Osorio; Bruno L Travi; Bruce A Luxon; Peter C Melby
Journal:  PLoS Pathog       Date:  2017-01-31       Impact factor: 6.823

4.  Macrophages as host, effector and immunoregulatory cells in leishmaniasis: Impact of tissue micro-environment and metabolism.

Authors:  Christian Bogdan
Journal:  Cytokine X       Date:  2020-10-12

5.  Immunomodulatory Potential of Non-Classical HLA-G in Infections including COVID-19 and Parasitic Diseases.

Authors:  Sajad Rashidi; Carmen Vieira; Renu Tuteja; Reza Mansouri; Mohammad Ali-Hassanzadeh; Antonio Muro; Paul Nguewa; Raúl Manzano-Román
Journal:  Biomolecules       Date:  2022-02-04

6.  Tissue Specific Dual RNA-Seq Defines Host-Parasite Interplay in Murine Visceral Leishmaniasis Caused by Leishmania donovani and Leishmania infantum.

Authors:  Sarah Forrester; Amy Goundry; Bruna Torres Dias; Thyago Leal-Calvo; Milton Ozório Moraes; Paul M Kaye; Jeremy C Mottram; Ana Paula C A Lima
Journal:  Microbiol Spectr       Date:  2022-04-06

Review 7.  Impairment of T cell function in parasitic infections.

Authors:  Vasco Rodrigues; Anabela Cordeiro-da-Silva; Mireille Laforge; Ali Ouaissi; Khadija Akharid; Ricardo Silvestre; Jérôme Estaquier
Journal:  PLoS Negl Trop Dis       Date:  2014-02-13

Review 8.  Immunomodulatory properties of HLA-G in infectious diseases.

Authors:  Laurence Amiot; Nicolas Vu; Michel Samson
Journal:  J Immunol Res       Date:  2014-04-15       Impact factor: 4.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.